-+ 0.00%
-+ 0.00%
-+ 0.00%

CABALETTA BIO INC: SYSTEMIC SCLEROSIS REGISTRATIONAL DISCUSSIONS WITH FDA ANTICIPATED IN 4Q25

Reuters·05/15/2025 11:00:01

Please log in to view news